We are live on ! Find out more
SFM

Soros Fund Management Portfolio holdings

AUM $9.12B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+30.69%
3 Year Est. Return
+70.05%
5 Year Est. Return
+69.93%
10 Year Est. Return
+534.14%
AUM
$10.1B
AUM Growth
-$1.66B
Cap. Flow
-$3.05B
Cap. Flow %
-30.19%
Top 10 Hldgs %
27.09%
Holding
392
New
156
Increased
60
Reduced
54
Closed
87

Top Buys

Rank Stock Value
1
HLF icon
Herbalife
HLF
+$112M
2
CTXS
Citrix Systems Inc
CTXS
+$94.6M
3
MNST icon
Monster Beverage
MNST
+$76.2M
4
BHI
Baker Hughes
BHI
+$61.5M
5
CMCSA icon
Comcast
CMCSA
+$60.8M

Sector Composition

Rank Sector Weight
1 Energy 14.62%
2 Technology 11.94%
3 Healthcare 10.05%
4 Communication Services 8.41%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INCY icon
226
Incyte
INCY
$24B
$1.24M 0.01%
+23,200
New +$1.44M
INVN
227
DELISTED
Invensense Inc
INVN
$1.23M 0.01%
+51,811
New +$1.08M
MANU icon
228
Manchester United
MANU
$3.9B
$1.2M 0.01%
69,703
-612,412
-90% -$9.37M
PPC icon
229
Pilgrim's Pride
PPC
$6.65B
$1.17M 0.01%
+55,918
New +$963K
ZNGA
230
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$1.07M 0.01%
250,000
-1,750,000
-88% -$8.07M
TWER
231
DELISTED
Towerstream Corporation Common Stock
TWER
$1.01M 0.01%
21,590
SFXE
232
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$1M 0.01%
+142,072
New +$1.27M
AMRI
233
DELISTED
Albany Molecular Research Inc
AMRI
$905K 0.01%
+48,700
New +$671K
MPAA icon
234
Motorcar Parts of America
MPAA
$257M
$810K 0.01%
+30,500
New +$696K
PALI icon
235
Palisade Bio
PALI
$337M
0
NWBO
236
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$793K 0.01%
+109,500
New +$649K
GIMO
237
DELISTED
Gigamon Inc.
GIMO
$760K 0.01%
+25,000
New +$787K
BEAT
238
DELISTED
BioTelemetry, Inc.
BEAT
$753K 0.01%
+74,600
New +$687K
GALT icon
239
Galectin Therapeutics
GALT
$200M
$738K 0.01%
+48,200
New +$686K
ARWR icon
240
Arrowhead Research
ARWR
$12.1B
$726K 0.01%
+44,200
New +$776K
ADEP
241
DELISTED
Adept Technology Inc
ADEP
$709K 0.01%
+37,300
New +$642K
BALT
242
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$709K 0.01%
+112,300
New +$712K
BIRT
243
DELISTED
Actuate Corp
BIRT
$708K 0.01%
117,576
-89,090
-43% -$587K
VRTX icon
244
Vertex Pharmaceuticals
VRTX
$119B
$707K 0.01%
+10,000
New +$792K
QUIK icon
245
QuickLogic
QUIK
$238M
$686K 0.01%
+9,407
New +$635K
OCLR
246
DELISTED
Oclaro Inc.
OCLR
$676K 0.01%
+218,100
New +$611K
KODK icon
247
Kodak
KODK
$828M
$642K 0.01%
19,228
BCRX icon
248
BioCryst Pharmaceuticals
BCRX
$2.24B
$632K 0.01%
+59,700
New +$636K
SRPT icon
249
Sarepta Therapeutics
SRPT
$1.68B
$601K 0.01%
25,000
-208,000
-89% -$5.3M
SNMX
250
DELISTED
Senomyx, Inc.
SNMX
$601K 0.01%
+56,300
New +$471K

Similar funds

Soros Fund Management's Q1 2014 Portfolio in Review

As of Q1 2014, Soros Fund Management held 392 positions worth $10.1B, down 14% from $11.8B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Soros Fund Management withdrew a net $3.05B in Q1 2014, closing 87 positions and reducing 54 holdings. Its most notable exit was JPMorgan Chase, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Soros Fund Management opened a new position in Baker Hughes worth $67.6M.

  • Soros Fund Management's largest Q1 2014 buy was Baker Hughes: 1,039,662 shares worth $67.6M.
  • Soros Fund Management added most to Herbalife in Q1 2014, an estimated $112M increase.
  • Soros Fund Management's biggest Q1 2014 reduction was Pioneer Natural Resource Co., cutting an estimated $163M.
  • Soros Fund Management fully exited JPMorgan Chase in Q1 2014, selling an estimated $166M.
  • Soros Fund Management's ten largest holdings make up 27% of its $10.1B portfolio in Q1 2014.
  • Soros Fund Management opened 156 new positions and closed 87 in Q1 2014.
  • Soros Fund Management's portfolio value fell 14% quarter-over-quarter to $10.1B.

Based on Soros Fund Management's 13F filing for Q1 2014, filed 15 May 2014.